Lyme Disease

References

Anderson, J.F. et al. 1987. Prevalence of Borrelia burgdorferi in white-footed mice and Ixodes dammini at Fort McCoy, Wis. J. Clin. Microbiol. 25:1495-1497.

Barthold, S.W. et al. 1995. Serologic responses of dogs naturally exposed to or vaccinated against Borrelia burgdorferi infection. J.A.V.M.A. 207:1435-1440.

Benach, J.L. et al. 1985. Serological evidence for simultaneous occurrences of Lyme disease and babesiosis. J. Infect. Dis. 152:473-477.

Benenson, A.S. (Ed.). 1995. Control of Communicable Diseases Manual. American Public Health Assoc.; Washington, D.C.

Bockenstedt, L.K. et al. 2002. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment. J. Infect. Dis. 186:1430-1437.

Brown, R.N. and R.S. Lane. 1992. Lyme disease in California: a novel enzootic transmission cycle of Borrelia burgdorferi. Science 256:1439-1442.

Burgess, E.C. 1992. Experimentally induced infection of cats with Borrelia burgdorferi. A.J.V.R. 53:1507-1511.

Burgess, E.C. and M. Mattison. 1987. Encephalitis associated with Borrelia burgdorferi infection in a horse. J.A.V.M.A. 191:1457-1458.

Burgess, E.C. et al. 1987. Arthritis and systemic disease caused by Borrelia burgdorferi infection in a cow. J.A.V.M.A. 191:1468-1470.

Burgess, E.C. et al. 1986. Arthritis and panuveitis as manifestations of Borrelia burgdorferi infection in a Wisconsin pony. J.A.V.M.A. 189:1340-1342.

Burgess, E.C. et al. 1989. Testing for Borrelia burgdorferi. J.A.V.M.A. 195:844-845.

Chang, Y.-F. et al.1995. Recombinant ospA protects dogs against infection and disease caused by Borrelia burgdorferi. Infect. Imm. 63:3543-3549.

Chang, Y.-F. et al. 2000. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses. Vaccine 18:540-548.

Chang, Y.-F. et al. 2001. Experimental induction of chronic borreliosis in adult dogs exposed to Borrelia burgdorferi-infected ticks and treated with dexamethasone. A.J.V.R. 62:1104-1112.

Chu, H.-J. et al. 1992. Immunogenicity and efficacy study of a commercial Borrelia burgdorferi bacterin. J.A.V.M.A. 201:403-411.

Coughlin, R.T. et al. 1995. Protection of dogs from Lyme disease with a vaccine containing outer surface protein (osp) A, OspB and saponin adjuvant QS21. J. Infect. Dis. 171:1049-1052.

Croke, C.L. et al. 2000. Occurrence of severe destructive Lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi. Infect. Immun. 68:658-663.

DeSilva, A.M. et al. 1997. OspA antibodies inhibit the acquisition of Borrelia burgdorferi by Ixodes ticks. Infect. Imm. 65:3146-3150.

Fritz, C.L. and A.M. Kjemtrup. 2003. Lyme borreliosis. J.A.V.M.A. 223:1261-1270.

Golde, W.T. et al. 1998. Culture-confirmed reinfection of a person with different strains of Borrelia burgdorferi sensu stricto. J. Clin. Microbiol. 36:1015-1019.

Greene, R.T. 1990. Lyme borreliosis, in: Infectious Diseases of the Dog and Cat (Ed. C.E. Greene), pp. 404-415. W.B. Saunders Co.; Philadelphia, PA.

Greene, C.E., M.J.G. Appel and R.K. Strauhbinger. 1998. Lyme borreliosis, in: Infectious Diseases of the Dog and Cat (Ed. C.E. Greene), pp. 282-293. W.B. Saunders Co.; Philadelphia, PA.

Gross, D.M. et al. 1998. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 281:703-706.

Gustafson, J.M. et al. 1993. Intrauterine transmission of Borrelia burgdorferi in dogs. A.J.V.R. 54:882-890.

Hinrichsen, V.L. et al. 2001. Assessing the association between the geographic distribution of deer ticks and seropositivity rates to various tick-transmitted disease organisms in dogs. J.A.V.M.A. 218:1092-1097.

Jackson, C.A. et al. 2002. Reassessment of a midwestern Lyme disease focus for Borrelia burgdorferi and the human granulocytic ehrlichiosis agent. J. Clin. Microbiol. 40:2070-2073.

Ji, B. and M.T. Collins. 1994. Seroepidemiologic survey of Borrelia burgdorferi exposure of dairy cattle in Wisconsin. A.J.V.R. 55:1228-1231.

Kazmierczak, J.J. and F.E. Sorhage. 1993. Current understanding of Borrelia burgdorferi infection, with emphasis on its prevention in dogs. J.A.V.M.A. 203:1524-1528.

Krause, P.J. et al. 1996. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. J.A.M.A. 275:1657-1660.

Levine, J.F. 1995. Ixodes-borne Borrelia spp. infections. J.A.V.M.A. 207:768-775.

Levy, S.A. et al. 1993. Performance of a Borrelia burgdorferi bacterin in borreliosis-endemic areas. J.A.V.M.A. 202:1834-1838.

Levy, S.A. and L.A. Magnarelli. 1992. Relationship between development of antibodies to Borrelia burgdorferi in dogs and the subsequent development of limb/joint borreliosis. J.A.V.M.A. 200:344-347.

Levy, S.A. et al. 1993. Canine lyme borreliosis. Comp. Cont. Ed. 15:833-846.

Lovrich, S.D. et al. 1994. Seroprotective groups of Lyme borelliosis spirochetes from North America and Europe. J. Infect. Dis. 170:115-121.

Lissman, B.A. et al. 1984. Spirochete-associated arthritis (Lyme disease) in a dog. J.A.V.M.A. 185:219-220.

Luke, C.J. et al. 1997. An ospA-based vaccine protects mice against infection with Borrelia burgdorferi. J. Infect. Dis. 175:91-97.

Magnarelli, L.A. et al. 1990. Tick parasitism and antibodies to Borrelia burgdorferi in cats. J.A.V.M.A. 197:63-66.

Magnarelli, L.A. et al. 1995. Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera. J. Clin. Microbiol. 33:3054-3057.

Mather, T.N. et al. 1994. Competence of dogs as reservoirs for Lyme disease spirochetes (Borrelia burgdorferi). J.A.V.M.A. 205:186-188.

Mathiesen, D.A. et al. 1997. Genetic heterogeneity of Borrelia burgdorferi in the United states. J. Infect. Dis. 175:98- 107.

Moore, V.A. et al. 2003. Detection of Borrelia lonestari, putative agent of southern tick-associated rash illness, in white-tailed deer (Odocoileus virginianus) from the southeastern United States. J. Clin. Microbiol;. 41:424-427.

Nadelman, R.B. et al. 2001. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N. Eng. J. Med. 345:79-84. (See also a series of follow-up letters to the editor in the N. Eng. J. Med. 345 [2001]:1348-1350)

Reed, K.D. 2002. Laboratory testing for Lyme disease: possibilities and practicalities. J. Clin. Microbiol. 40:319-324.

Richter, D. et al. 2000. Competence of American robins as reservoir hosts for lyme disease spirochetes. Emerg. Infect. Dis. 6:133-138.

Roush, J.K. et al. 1989. Rheumatoid arthritis subsequent to Borrelia burgdorferi infection in two dogs. J.A.V.M.A. 195:951-953.

Shapiro, E.D. et al. 1992. A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. N. Eng. J. Med. 327:1769-1773.

Sigal, L.H. et al. 1998. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. N. Eng. J. Med. 339:216-222.

Simon, M.M. et al. 1991. Recombinant outer surface membrane protein A from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice. J. Infect. Dis. 164:123-132.

State and District of Columbia Health Departments, et al. 2002. Lyme disease - United States, 2000. M.M.W.R. 51:29-31.

Steere, A.C.. 1995. Borrelia burgdorferi (Lyme disease, Lyme borreliosis), in: Principles and Practice of Infectious Diseases (Eds. G.L. Mandel, J.E. Bennett and R. Dolin), pp. 2143-2155. Churchill Livingston, Inc.; New York, NY.

Steere, A.C. 2001. Lyme disease. N. Eng. J. Med. 3445:115-125.

Steere, A.C., E. Dwyer and R. Winchester. 1990. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 allelles. N. Eng. J. Med. 323:219-223.

Steere, A.C. et al. 1998. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N. Eng. J. Med. 339:209-215.

Straubunger, R.K. et. al. 1997. Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J. Clin. Microbiol. 35:111-116.

Straubunger, R.K. et al. 2000. Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: an experimental study. J. Infect. Dis. 181:1069-1081.

Varela, A.S. et al. 2004. First culture isolation of Borrelia lonestari, putative agent of southern tick-associated rash illness. J. Clin. Microbiol. 42:1163-1169.

Wasmoen, T.L. et. al. 1992. Examination of Koch's postulates for Borrelia burgdorferi as the causative agent of limb/joint dysfunction in dogs with borreliosis. J.A.V.M.A. 201:412-418.

Yang, L. et. al. 1994. Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect. Imm. 62:492-500.

  Previous Lyme disease topic

 Return to Lyme disease introductory page